Can Ozempic help lower your risk of dementia?

Translate to Spanish or other 102 languages!

According to Alzheimer’s Disease International, as of 2020, there were over 55 million peopleliving with dementia, with that number expected to rise to 78 million by 2030. Image for illustration purposes
According to Alzheimer’s Disease International, as of 2020, there were over 55 million peopleliving with dementia, with that number expected to rise to 78 million by 2030. Image for illustration purposes
- Advertisement -

Medical News Today

  • There are several risk factors for dementia, including type 2 diabetes and obesity. 
  • A new study reports that semaglutide — the active ingredient in GLP-1 medications Ozempic and Wegovy for type 2 diabetes and weight loss — may help lower dementia risk in people with type 2 diabetes. 
  • Researchers say semaglutide targets several dementia risk factors and is anti-inflammatory, which could explain this benefit to brain health.

According to Alzheimer’s Disease International, as of 2020, there were over 55 million peopleliving with dementia, with that number expected to rise to 78 million by 2030.

Follow the link below to Medical News Today to read the full story:

- Advertisement -

https://www.medicalnewstoday.com/articles/can-ozempic-weight-loss-diabetes-help-lower-risk-vascular-dementia?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-07-23&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Study Points to High Blood Pressure as a Key Factor in Rising Heart Disease Rates

Heart disease is the leading cause of death in the United States according to the Journal of the American College of Cardiology. Its impact extends beyond biology, with social detriments such as food insecurity, socioeconomic status and education influencing outcomes.

Dysfunctional, Not Missing, Immune Cells Explain Skin Cancer Risk in Immunosuppressed Patients

Researchers at The University of Texas MD Anderson Cancer Center have discovered that immunosuppressed patients with non-melanoma skin cancer are not missing the key cancer-fighting immune cells found in immunocompetent patients, but those cells – known as macrophages – have lost the ability to communicate effectively.

New Study Reveals Real-World Safety Findings for Latest Alzheimer’s Treatment

As new Alzheimer’s drugs move from clinical trials into everyday care, families are asking whether these treatments are safe, how long patients can stay on them, and whether they truly slow the disease outside tightly controlled studies.

The Truth About Liver Detoxes

Many health trends seem to come and go, but there are some that always find a way of resurfacing – like detoxing your liver.
- Advertisement -